Royal London Asset Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $13.6M | Buy |
|
|||||
|
2025
Q2 | $7.68M | Sell |
|
|||||
|
2025
Q1 | $8.08M | Buy |
|
|||||
|
2024
Q4 | $10.9M | Buy |
|
|||||
|
2024
Q3 | $9.62M | Buy |
|
|||||
|
2024
Q2 | $10.4M | Sell |
|
|||||
|
2024
Q1 | $12.6M | Sell |
|
|||||
|
2023
Q4 | $11.5M | Buy |
|
|||||
|
2023
Q3 | $11.7M | Buy |
|
|||||
|
2023
Q2 | $10.8M | Buy |
|
|||||
|
2023
Q1 | $8.62M | Buy |
|
|||||
|
2022
Q4 | $5.52M | Hold |
|
|||||
|
2022
Q3 | $5.77M | Sell |
|
|||||
|
2022
Q2 | $7.44M | Hold |
|
|||||
|
2022
Q1 | $10.1M | Buy |
|
|||||
|
2021
Q4 | $10.4M | Hold |
|
|||||
|
2021
Q3 | $9.46M | Hold |
|
|||||
|
2021
Q2 | $8M | Hold |
|
|||||
|
2021
Q1 | $6.28M | Buy |
|
|||||
|
2020
Q4 | $6.05M | Buy |
|
|||||
|
2020
Q3 | $5.66M | Buy |
|